MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-12-2025
Interpace Biosciences Operating Cash Flow 2011-2026 | IDXG
Annual Operating Cash Flow Interpace Biosciences
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.65 M | 3.79 M | -7.69 M | -8.72 M | -14 M | -19 M | -8.67 M | -15.3 M | -7.61 M | -19.8 M | -16.4 M | -3.51 M | -10.3 M | 1.98 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.65 M | -19.8 M | -8.61 M |
Quarterly Operating Cash Flow Interpace Biosciences
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 1.24 M | - | - | - | -58 K | - | - | - | 1.13 M | - | -7.42 M | -4.17 M | -1.25 M | - | -7.5 M | -6.82 M | -5.01 M | - | -12.4 M | -6.67 M | -7.12 M | - | -12.6 M | -7.78 M | -2.96 M | - | -6.8 M | -5.03 M | -2.49 M | - | -12.9 M | -8.57 M | -4.15 M | - | -6.62 M | -5.27 M | -3.97 M | - | -13.5 M | -8.14 M | -5.62 M | - | -7.97 M | -8.29 M | -6.46 M | - | 237 K | -574 K | 1.22 M | - | -3.16 M | -6.84 M | -2.35 M | - | 3.08 M | 1.57 M | 1.76 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.08 M | -13.5 M | -4.88 M |
Operating Cash Flow of other stocks in the Diagnostics research industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Anixa Biosciences
ANIX
|
-7.17 M | $ 3.03 | -2.26 % | $ 98.3 K |  USA |
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
-32.2 M | - | -6.19 % | $ 10.5 M | USA |
 |
Castle Biosciences
CSTL
|
64.9 M | $ 39.83 | 1.7 % | $ 1.11 B | USA |
 |
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | USA |
 |
Brainsway Ltd.
BWAY
|
884 K | $ 23.52 | -2.2 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
-478 M | $ 34.0 | 0.68 % | $ 366 M |  China |
 |
Accelerate Diagnostics
AXDX
|
-48.7 M | - | -61.36 % | $ 2.46 M | USA |
 |
Exact Sciences Corporation
EXAS
|
211 M | $ 102.43 | 0.13 % | $ 19 B | USA |
 |
Fulgent Genetics
FLGT
|
21.1 M | $ 26.13 | -0.44 % | $ 790 M | USA |
 |
BioNano Genomics
BNGO
|
-68.9 M | $ 1.3 | -11.56 % | $ 1.65 M | USA |
 |
Guardant Health
GH
|
-240 M | $ 111.99 | 1.37 % | $ 13.7 B | USA |
 |
Check-Cap Ltd.
CHEK
|
-8 M | - | - | $ 9.42 M | Israel |
 |
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | USA |
 |
Co-Diagnostics
CODX
|
-22.1 M | - | - | $ 79.8 M | USA |
 |
Danaher Corporation
DHR
|
6.69 B | $ 218.32 | -0.59 % | $ 160 B | USA |
 |
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | USA |
 |
Lantheus Holdings
LNTH
|
545 M | $ 66.61 | -0.1 % | $ 4.61 B | USA |
 |
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
-5.66 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-524 M | - | 0.12 % | $ 80.1 M | China |
 |
DexCom
DXCM
|
748 M | $ 73.22 | -1.05 % | $ 28.3 B | USA |
 |
NeoGenomics
NEO
|
7.02 M | $ 11.91 | -3.95 % | $ 1.51 B | USA |
 |
CareDx, Inc
CDNA
|
-18.4 M | $ 20.33 | -2.26 % | $ 1.09 B | USA |
 |
Celcuity
CELC
|
-83.5 M | $ 108.09 | -3.59 % | $ 4.26 B | USA |
 |
DarioHealth Corp.
DRIO
|
-30.4 M | $ 10.14 | -1.55 % | $ 288 M | Israel |
 |
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K | USA |
 |
Personalis
PSNL
|
-45.2 M | $ 9.27 | -7.02 % | $ 549 M | USA |
 |
Heska Corporation
HSKA
|
-21.8 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-18.4 M | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
837 M | $ 144.04 | -3.77 % | $ 22.9 B | USA |
 |
QIAGEN N.V.
QGEN
|
674 M | - | - | $ 10.6 B |  Niderland |
 |
IQVIA Holdings
IQV
|
2.72 B | $ 229.24 | -2.71 % | $ 41.6 B | USA |
 |
Charles River Laboratories International
CRL
|
735 M | $ 208.45 | -1.53 % | $ 10.7 B | USA |
 |
Thermo Fisher Scientific
TMO
|
8.67 B | $ 575.61 | -2.79 % | $ 220 B | USA |
 |
Trinity Biotech plc
TRIB
|
13.2 M | $ 0.81 | -7.96 % | $ 61.9 M |  Irlanda |
 |
Twist Bioscience Corporation
TWST
|
-47.6 M | $ 40.92 | -1.59 % | $ 2.45 B | USA |
 |
Medpace Holdings
MEDP
|
609 M | $ 581.54 | -1.94 % | $ 18 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.33 B | $ 185.97 | 1.99 % | $ 20.6 B | USA |
|
Biodesix
BDSX
|
-48.6 M | $ 9.61 | -0.57 % | $ 1.25 B | USA |
 |
Motus GI Holdings
MOTS
|
-11.2 M | - | -34.28 % | $ 263 K | Israel |
 |
Precipio
PRPO
|
-3.56 M | $ 24.39 | 0.54 % | $ 31.7 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.59 B | $ 269.91 | 0.04 % | $ 22.6 B | USA |
 |
Mettler-Toledo International
MTD
|
968 M | $ 1 376.67 | -1.16 % | $ 29.2 B |  Schweiz |
 |
ICON Public Limited Company
ICLR
|
1.29 B | $ 179.26 | -3.57 % | $ 14.8 B | Irlanda |
 |
IDEXX Laboratories
IDXX
|
929 M | $ 673.4 | -0.49 % | $ 55.5 B | USA |